Tygh Capital Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$6.33M Buy
126,100
+849
+0.7% +$43.9K 0.81% 55
2021
Q3
$6.65M Sell
125,251
-71,094
-36% -$4M 0.9% 59
2021
Q2
$12M Sell
196,345
-80,076
-29% -$4.25M 1.63% 21
2021
Q1
$13.5M Buy
276,421
+11,014
+4% +$516K 1.91% 14
2020
Q4
$10.7M Sell
265,407
-8,750
-3% -$313K 1.67% 17
2020
Q3
$8.92M Buy
274,157
+94,489
+53% +$2.84M 1.69% 18
2020
Q2
$4.74M Buy
179,668
+130,199
+263% +$3.4M 0.99% 46
2020
Q1
$1.23M Buy
+49,469
New +$1.53M 0.28% 72

Other funds holding LMAT

Tygh Capital Management's LMAT Position: Q4 2021 in Review

Tygh Capital Management increased its LeMaitre Vascular (LMAT) stake by 0.68% in Q4 2021, buying an estimated $43.9K and bringing the position to 126,100 shares worth $6.33M. The position accounts for 0.81% of the portfolio, ranked #55.

Tygh Capital Management first reported a position in LMAT in Q1 2020 and has held it in 8 quarters since. The position peaked at $13.5M in Q1 2021. 181 funds tracked by Wall St. Rank hold LMAT as of Q4 2021.

  • Tygh Capital Management held 126,100 shares of LeMaitre Vascular worth $6.33M as of Q4 2021.
  • Tygh Capital Management bought 849 LeMaitre Vascular shares in Q4 2021, an estimated $43.9K.
  • LeMaitre Vascular made up 0.81% of Tygh Capital Management's portfolio in Q4 2021, its #55 holding.
  • Tygh Capital Management first reported a position in LeMaitre Vascular in Q1 2020 and has held it in 8 quarters since.
  • Tygh Capital Management's LeMaitre Vascular position peaked at $13.5M in Q1 2021.
  • 181 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2021.

Based on Tygh Capital Management's 13F filing for Q4 2021, filed 10 Feb 2022.